http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0371139-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630b360599ea5cf4b5bcbc0c6c0a3e2d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 |
| filingDate | 1989-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1994-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed8dc54e14add66dda637945f99d3229 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67abfcfc3c527ad21d88021a026daa61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a225a8c8868a8c2cdcdb3523fadd9dfd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00983bab86c3adef9872e89c99348ec1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8a68bf6a428e2db78c87d0de3ea0468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9a786cd667d95ae430d2ab9290dde1a |
| publicationDate | 1994-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0371139-B1 |
| titleOfInvention | 6-substituted acyclicpyrimidine nucleoside derivatives and antiviral agents containing same as active ingredients |
| abstract | 6-Substitued acyclicpyrimidine nucleoside derivatives represented by general formula (I) (wherein R<1> represents a hydrogen atom, a halogen atom, an alkyl group, an alkenyl group, an alkylcarbonyl group, an arylcarbonyl group, an arylcarbonylalkyl group, an arylthio group or an aralkyl group, R<2> represents an arylthio group, an alkylthio group, a cycloalkylthio group, an arylsulfoxido group, an alkylsulfoxido group, a cycloalkylsulfoxido group, an alkenyl group, an alkynyl group, an aralkyl group, an arylcarbonyl group, an arylcarbonylalkyl group or an aryloxy group, R<3> represents a hydroxyalkyl group whose alkyl moiety may be interrupted by an oxygen atom, X represents an oxygen atom, a sulfur atom or an amino group, Y represents an oxygen atom or a sulfur atom, and A represents =N- or -NH-) or pharmaceutically acceptable salts thereof, a process for preparing these compounds, and antiviral agents containing the compounds as active ingredients are disclosed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7037917-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8003789-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7887845-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8530655-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6878717-B2 |
| priorityDate | 1988-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 360.